RadioShack taps Magnacca as CEO, ‘catalyst for change’
Everybody loves a turnaround story. RadioShack is betting that the now-former president of daily living products and solutions for Walgreens, Joe Magnacca, will help author a turnaround story of its own for the small-box consumer electronics retailer.
RadioShack stopped the presses late Thursday evening with news that Magnacca had agreed to join the company as CEO — less than one week removed from Magnacca’s promotion from a corporate SVP to EVP of Walgreens, in addition to his title as president of daily living products and solutions. Magnacca — who came to Walgreens in the 2010 acquisition of Duane Reade, where he had served as president — replaces CFO Dorvin Lively in the top spot at Radio Shack. Lively had served in the role on an interim basis since September following the departure of former CEO James Gooch. Prior to Duane Reade, Magnacca was SVP at Shoppers Drug Mart.
In the wake of Magnacca’s departure, Bryan Pugh, VP well experience deployment, will lead the merchandising group for Walgreens on an interim basis.
“I am delighted to join RadioShack and to be part of this team as we build upon the strengths of such a great brand,” Magnacca noted. “I see advantages in being a small-box retailer in the consumer electronics space today, particularly with the broad retail footprint and convenience that RadioShack offers its customers. I believe my experiences will help the team identify and execute on new opportunities that can return this great company to a position of prominence in the lexicon of American retailers.”
Magnacca has good reason to be confident — so far he has demonstrated a rather deft hand at helping to lead turnaround stories and transforming the retail experience for customers. Magnacca was the major visionary behind the health and daily living store concept that shapes Walgreens’ Well Experience stores, which are modeled largely after the new format Magnacca pioneered at Duane Reade.
The transformation of the Duane Reade stores was a major reason Walgreens moved to acquire the company in 2010, Walgreens president and CEO Greg Wasson told DSN in an exclusive interview last summer. Wasson described the acquisition as an accelerant of one of five key strategic growth imperatives for Walgreens, to transform the traditional drug store into a health and daily living destination. “Duane Reade had started the new drug store concept, and now you see a lot of that infuence coming back to Walgreens and accelerating where we’re headed,” Wasson told DSN last August.
It is clear that RadioShack’s board is looking for Magnacca to bring some of that magic to its stores. “Joe is a leader with significant experience in transforming iconic brand names into strong operating businesses,” noted RadioShack non-executive chairman Daniel Feehan. “We believe he will be a catalyst for change at RadioShack in refining our merchandising strategies, reinvigorating the shopping experience for our customers and building sustainable value for our shareholders.”
RadioShack needs the help, coming off of three consecutive quarters of losses. The company posted a third-quarter loss of $76 million.
Unlike finance guys Gooch and Lively, Magnacca brings a different perspective to the job — a merchant’s perspective. With 4,700 stores in the United States and Mexico, the company has an opportunity to outflank its biggest competitor Best Buy in markets all across the country. And in the era of omnichannel retailing, that kind of footprint could enable Radio Shack to better compete against the Amazons of the world that are still trying to figure out a scalable solution for same-day delivery. Clearly, the company is putting together the team to lead a transformation. In December, Radio Shack added former head of Target store operations Troy Risch as EVP operations and former Sam’s Club exec Huey Long as EVP marketing, business development and multichannel.
In the wake of Magnacca’s departure, Walgreens DVP corporate communications Michael Polzin noted, "We wish Joe the best in his new role, which reflects the depth and talent in our organization. Bryan Pugh, VP well experience deployment, will be leading our daily living and merchandising operations on an interim basis, reporting to Mark Wagner, president of operations and community management. The strength of our leadership team allows us to continue moving forward with our key strategy of creating a well experience for our customers.”
99 Cents Only Stores sales increase 8.8% in Q3
CITY OF COMMERCE, Calif. — Net sales at 99 Cents Only Stores increased 8.8% in third quarter 2013, the company said.
The dollar-store chain announced sales of $439.5 million, a $35.6 million increase over third quarter 2012, while comps increased 4.3%. For the first three quarters of fiscal year 2013, sales were $1.23 billion, an 8.7% increase over the same period last year, while comps increased 4.3%. Profit for the quarter was $12.7 million, compared with $22.2 million at the end of third quarter 2012.
The company opened seven new stores during the quarter, including four in California, one in Nevada and two in Texas, while closing one store in California following the expiration of a lease. In total, the company operated 309 stores, a 5.8% increase in store count over the year before.
Vaccine-resistant whooping cough bacteria strain may have appeared in U.S., researchers say
NEW YORK — A new strain of the bacterium that causes whooping cough immune to vaccines may have appeared in the United States, according to a brief published Thursday in the New England Journal of Medicine.
The brief, filed by officials from the Centers for Disease Control and Prevention and other health authorities, reported that a strain of Bordetella pertussis had been reported in Japan, France and Finland and may have appeared in Philadelphia, where 12 children were hospitalized between 2011 and 2012.
The new strain tests negative for pertactin, a protein involved in the bacteria’s infection of humans and a component of acellular vaccines — vaccines that contain parts of cells as opposed to whole cells — used to prevent whooping cough. When researchers analyzed the Philadelphia samples, 11 of the 12 were found to test negative for pertactin.
The researchers suggested more testing of samples from around the country in order to help understand the new pertactin-negative variants of the bacteria.